Heterocyclic scaffolds represent crucial frameworks in modern drug development owing to their wide range of biological effects. Among these, quinoline derivatives exhibit notable antibacterial, anti-inflammatory, antimalarial, and anticancer activities. Thienoquinoline, a fused analogue of quinoline, has recently emerged as a promising structure with significant antiproliferative potential. Research findings suggest that these compounds can modulate vital molecular pathways responsible for cancer progression and cell survival. This review highlights current insights into the biological evaluation and significance of thienoquinoline derivatives, emphasizing their prospective utility as antiproliferative agents.
No takes yet. Share an insight, caveat, or question.
Dave et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: